Back Source: > 28 November 2009 (E-Business) Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise New report "Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" available through Aarkstore.com  Indevus Pharmaceuticals, Inc. (Indevus), a specialty pharmaceutical company, is engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The company has four major product namely SANCTURA and SANCTURA XR for overactive bladder (OAB); VANTAS for advanced prostate cancer; SUPPRELIN LA for central precocious puberty (CPP), and DELATESTRYL for the treatment of hypogonadism. Its pipeline product includes VALSTAR for bladder cancer, NEBIDO for hypogonadism, PRO 2000 for the prevention of infection by human immunodeficiency virus (HIV) and other sexually transmitted diseases. Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. For more information please visit : http://www.aarkstore.com/reports/Indevus-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-20027.html  Visit